Role of cross-mixing tests in differentiating etiologies of prolonged aPTT: a single-center retrospective study.

Nahomi Suita, Aozora Kanemaru, Noriko Komori, Koichi Nitta, Haruyuki Fujita, Hiroshi Kawabata

Abstract read

In one paragraph

Article in International journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nahomi SuitaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata‑Cho, Fushimi‑Ku, Kyoto, 612‑8555, Japan.

Aozora KanemaruDepartment of Clinical Laboratory, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata‑Cho, Fushimi‑Ku, Kyoto, 612‑8555, Japan.

Noriko KomoriDepartment of Clinical Laboratory, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata‑Cho, Fushimi‑Ku, Kyoto, 612‑8555, Japan.

Koichi NittaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata‑Cho, Fushimi‑Ku, Kyoto, 612‑8555, Japan.

Haruyuki FujitaDepartment of Clinical Laboratory, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata‑Cho, Fushimi‑Ku, Kyoto, 612‑8555, Japan.

Hiroshi KawabataDepartment of Hematology, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata‑Cho, Fushimi‑Ku, Kyoto, 612‑8555, Japan. hkawabatdnks@gmail.com.ORCID http://orcid.org/0000-0002-1918-8635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reviewed 70 patients with prolonged activated partial thromboplastin time (aPTT) who underwent cross‑mixing tests (CMT) at our hospital. Median age was 70 years, median aPTT was 65.8 s, and 41 (58.5%) underwent CMT for preoperative screening. Visual CMT showed 13 deficiency‑pattern, 4 inhibitor‑pattern, and 53 lupus anticoagulant (LAC)‑pattern cases. Direct oral anticoagulants (DOACs) explained one deficiency‑pattern and two LAC‑pattern cases. All inhibitor‑pattern patients presented with bleeding and were diagnosed with acquired hemophilia A (AHA). Based on additional tests, including dilute Russell's viper venom time, LAC was considered the cause of aPTT prolongation in 59 cases (84.3%). No congenital hemophilia was identified. In CMT, an increase in aPTT after incubation in 50% mixed plasma clearly differentiated AHA (> 30 s) from LAC (< 25 s). All preoperative cases were ultimately attributed to LAC or DOACs; 37 patients proceeded to surgery without abnormal bleeding. These findings suggest that most preoperative aPTT prolongations seen in community practice are due to LAC, whereas AHA is rare. CMT provides same‑day results and is useful for rapidly excluding AHA in preoperative evaluation.

Indexed as

Hemophilia AAdultAgedAged, 80 and overBlood Coagulation TestsDiagnosis, DifferentialFemaleHumansLupus Coagulation InhibitorMaleMiddle AgedPartial Thromboplastin TimeRetrospective StudiesLupus Coagulation InhibitorAcquired hemophiliaActivated partial thromboplastin timeCross-mixing testLupus anti-coagulant

Identifiers

PMID42204127

DOI10.1007/s12185-026-04217-y

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.